Reducing the Blood Pressure-Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control

J Am Heart Assoc. 2015 Oct 27;4(10):e002276. doi: 10.1161/JAHA.115.002276.

Abstract

Background: US blood pressure reduction policies are largely restricted to hypertensive populations and associated benefits are often estimated based on unrealistic interventions.

Methods and results: We used multivariable linear regression to estimate incidence rate differences contrasting the impact of 2 pragmatic hypothetical interventions to reduce coronary heart disease, stroke, and heart failure (HF) incidence: (1) a population-wide intervention that reduced systolic blood pressure by 1 mm Hg and (2) targeted interventions that reduced the prevalence of unaware, untreated, or uncontrolled blood pressure above goal (per Eighth Joint National Committee treatment thresholds) by 10%. In the Atherosclerosis Risk in Communities Study (n=15 744; 45 to 64 years at baseline, 1987-1989), incident coronary heart disease and stroke were adjudicated by physician panels. Incident HF was defined as the first hospitalization with discharge diagnosis code of "428." A 10% proportional reduction in unaware, untreated, or uncontrolled blood pressure above goal resulted in ≈4.61, 3.55, and 11.01 fewer HF events per 100,000 person-years in African Americans, and 3.77, 1.63, and 4.44 fewer HF events per 100 000 person-years, respectively, in whites. In contrast, a 1 mm Hg population-wide systolic blood pressure reduction was associated with 20.3 and 13.3 fewer HF events per 100 000 person-years in African Americans and whites, respectively. Estimated event reductions for coronary heart disease and stroke were smaller than for HF, but followed a similar pattern for both population-wide and targeted interventions.

Conclusions: Modest population-wide shifts in systolic blood pressure could have a substantial impact on cardiovascular disease incidence and should be developed in parallel with interventions targeting populations with blood pressure above goal.

Keywords: blood pressure; coronary heart disease; epidemiology; heart failure; stroke.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Black or African American
  • Blood Pressure / drug effects*
  • Coronary Disease / diagnosis
  • Coronary Disease / ethnology
  • Coronary Disease / prevention & control*
  • Female
  • Heart Failure / diagnosis
  • Heart Failure / ethnology
  • Heart Failure / prevention & control*
  • Humans
  • Hypertension / diagnosis
  • Hypertension / drug therapy*
  • Hypertension / ethnology
  • Hypertension / physiopathology
  • Incidence
  • Linear Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prevalence
  • Preventive Health Services / methods*
  • Prospective Studies
  • Protective Factors
  • Risk Assessment
  • Risk Factors
  • Stroke / diagnosis
  • Stroke / ethnology
  • Stroke / prevention & control*
  • Time Factors
  • Treatment Outcome
  • United States / epidemiology
  • White People

Substances

  • Antihypertensive Agents